Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07129226 · ClinicalTrials.gov registry record · NA
Musculoskeletal Cancers Remote Monitoring and Care
A NA study of Osteosarcoma and Metastatic Bone Disease, sponsored by Case Comprehensive Cancer Center.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT07129226: Recruiting NA study of Osteosarcoma and Metastatic Bone Disease, sponsored by Case Comprehensive Cancer Center.
NCT07129226 is a NA study of Osteosarcoma and Metastatic Bone Disease that is actively recruiting participants, run by Case Comprehensive Cancer Center. The registered enrollment target is 60 participants, below the 300-participant average among 46 other Osteosarcoma trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07129226, a NA study of Osteosarcoma and Metastatic Bone Disease, is actively recruiting participants, sponsored by Case Comprehensive Cancer Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to evaluate how walking stability and the ability to perform daily activities change during cancer treatment, and whether a smartwatch can detect these changes. The goal is to develop proactive, personalized tools that automatically monitor treatment response and predict potential complications. To support future implementation, the study will assess the feasibility of wearing a smartwatch for at least 12 hours per day, using a mobile application, and completing weekly questionnaires among patients with primary osteosarcoma or metastatic bone disease.
Primary Outcome
Adherence in each case involves averaging ≥ 12h/day wear time and completion in ≥10 out of 12 weeks of the TESS instrument
Conditions Studied
Interventions
- OTHER Smart Watch
Study Locations (1)
Ohio
- Case Comprehensive Cancer Center, Cleveland Clinic Foundation - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2026-02-11 |
| Est. Completion | 2026-08 |
| Phase | NA |
What NCT07129226 shows while recruiting
NCT07129226 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 300-participant average among 46 other Osteosarcoma trials with a reported enrollment target (80% lower).
The record links to 2 conditions, with Osteosarcoma appearing as the primary indexed condition, and to 1 intervention - of which Smart Watch is the first listed.
NCT07129226 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT07129226 about?
NCT07129226 is a clinical study titled "Musculoskeletal Cancers Remote Monitoring and Care". This study aims to evaluate how walking stability and the ability to perform daily activities change during cancer treatment, and whether a smartwatch can detect these changes. The goal is to develop proactive, personalized tools that automatically monitor treatment response and predict potential co...
What is the current status of trial NCT07129226?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2026-02-11. Estimated completion is 2026-08.
What conditions does trial NCT07129226 study?
This clinical trial studies the following conditions: Osteosarcoma, Metastatic Bone Disease.
What interventions are being tested in trial NCT07129226?
The interventions under investigation include: Smart Watch (OTHER).
Who is sponsoring clinical trial NCT07129226?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07129226 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteosarcoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07129226's enrollment target sits among peer trials
60 18th of 46 higher than 28 of 46 other Osteosarcoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Osteosarcoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study to Evaluate the Utilization of 3D Printed Models in Pre-Operative Planning
RECRUITING · NA
-
Chemotherapy Resistance in Osteogenic Sarcoma and Other Solid Tumors
ACTIVE NOT RECRUITING · NA
-
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
RECRUITING · Phase 1
-
B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)
RECRUITING · Phase 1
-
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
RECRUITING · Phase 1
-
Losartan + Sunitinib in Treatment of Osteosarcoma
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI